Related Experiment Video
Updated: Feb 23, 2026

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
A functional genomics predictive network model identifies regulators of inflammatory bowel disease
Lauren A Peters1,2,3, Jacqueline Perrigoue4, Arthur Mortha5,6
1Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
This study develops a predictive model for the immune component of inflammatory bowel disease (IBD). It identifies key genes that regulate IBD, offering new insights into disease mechanisms and potential therapeutic targets.
Area of Science:
- Immunology
- Genetics
- Computational Biology
Background:
- Integrating diverse datasets is crucial for developing predictive models of inflammatory bowel disease (IBD).
- Genome-wide association studies (GWAS) have identified numerous loci associated with IBD, but their causal relationships and regulatory mechanisms remain unclear.
Purpose of the Study:
- To construct a predictive model of the immune component of IBD by integrating genetic, molecular, and clinical data.
- To identify causal relationships among IBD-associated loci using functional and regulatory annotations.
- To discover and experimentally validate key regulatory genes that modulate IBD pathophysiology.
Main Methods:
- Developed a predictive model using molecular data from intestinal samples of IBD patients across different disease stages.
- Integrated functional and regulatory annotations with GWAS data to infer causal networks.
- Performed key driver analysis to identify critical regulatory genes.
- Experimentally validated the top predicted key driver genes.
Main Results:
- Constructed a predictive model integrating genetic, molecular, and clinical data for IBD.
- Identified causal relationships among IBD-associated genetic loci.
- Prioritized and experimentally validated 12 key driver genes that regulate IBD-associated processes.
- Discovered novel regulators of central IBD processes.
Conclusions:
- The validated key driver set provides new insights into IBD pathogenesis.
- The model offers integrated circuits of genetic, molecular, and clinical traits for IBD research.
- This framework can be queried to refine the understanding of IBD regulatory networks.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Pharmacogenomics: Identification of New Drug Targets
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

